Emergency Medicine Doctors in Columbia, MD Accepting Medicare

30 Emergency Medicine doctors found. Showing 21 - 30

Willie Bivings, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-550-9720

Nicholas Pereira Risko, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-740-7890

Dr. Patricia Elizabeth Van Leer, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5575 Cedar Ln, Department Of Emergency Medicine, Columbia, MD 21044 Phone: 410-740-7777

Dr. Steven Perry Pakes, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 11849 Winterlong Way, Columbia, MD 21044 Phone: 410-992-3430

Dylan Lescure, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-740-7777    Fax: 410-740-7551

Kevin Cooke, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-550-9720

Mr. F S Martinez, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-884-4746

Ann Mihalick, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-550-9720

Dr. Howard Jeffery Morris, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-884-4746

Jessica Shackman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5755 Cedar Ln, Columbia, MD 21044 Phone: 410-740-7890

News Archive

Scientists warn of urban malaria in Africa and South East Asia

Scientists at the Liverpool School of Tropical Medicine are alerting the world to what they see as a new emerging tropical disease - that of urban malaria in Africa and South East Asia.

Preclinical data for potent IDO pathway inhibitor presented at AACR 2013 annual meeting

NewLink Genetics Corporation, a biopharmaceutical company primarily focused on discovering, developing and commercializing immunotherapeutic products in oncology, announced today that the company presented preclinical data for NLG919, a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, at the American Association for Cancer Research 2013 annual meeting.

Study highlights gap between men and women who suffer from heart attack

Women are more likely to die after a heart attack than men because they are often not prescribed the drugs they need. That's the result of research presented today on ACVC Essentials 4U, a scientific platform of the European Society of Cardiology (ESC).

Chronic pain patients at high-risk for comorbid substance abuse benefit from 3-week program

Research presented at the American Academy of Pain Medicine's 28th Annual Meeting shows that substance use education incorporated into a cognitive behavioral rehabilitation programming is effective to improve pain and function for the chronic pain patient at high-risk for comorbid substance abuse.

Read more Medical News

› Verified 3 days ago

• 1
• 2(current)